Abstract is: Julian P. T. Higgins is a British biostatistician, Professor of Evidence Synthesis and Director of Research at the Department of Population Health Sciences at the University of Bristol. Higgins was previously Chair in Evidence Synthesis at the University of York, and Programme Leader at the MRC Biostatistics Unit in Cambridge. He is also a founding trustee and a Past-President of the Society for Research Synthesis Methodology.
| human | Q5 |
| P227 | GND ID | 1198149108 |
| P2671 | Google Knowledge Graph ID | /g/11f6594xf8 |
| P1960 | Google Scholar author ID | EYQIr1sAAAAJ |
| P269 | IdRef ID | 132422530 |
| P213 | ISNI | 0000000384967261 |
| P8189 | J9U ID | 987007453534805171 |
| P244 | Library of Congress authority ID | n2008182317 |
| P1006 | Nationale Thesaurus voor Auteursnamen ID | 317524623 |
| P1207 | NUKAT ID | n2015004878 |
| P856 | official website | https://research-information.bris.ac.uk/en/persons/cddd7691-abca-46cb-8fa6-3b01745c2b98 |
| P496 | ORCID iD | 0000-0002-8323-2514 |
| P12458 | Parsifal cluster ID | 769851 |
| P1053 | ResearcherID | H-4008-2011 |
| P1153 | Scopus author ID | 55616553600 |
| P214 | VIAF cluster ID | 279510812 |
| P10832 | WorldCat Entities ID | E39PBJgCQhkmHY3QvD3dkYMwYP |
| P512 | academic degree | Doctor of Philosophy | Q752297 |
| P185 | doctoral student | Dean Langan | Q125423626 |
| P69 | educated at | University of Reading | Q1432632 |
| P108 | employer | Imperial College London | Q189022 |
| University College London | Q193196 | ||
| University of Bristol | Q459506 | ||
| University of York | Q967165 | ||
| Bristol Medical School | Q4968954 | ||
| Strangeways Research Laboratory | Q21686504 | ||
| MRC Biostatistics Unit | Q30280314 | ||
| University College London Medical School | Q86019097 | ||
| P734 | family name | Higgins | Q15868032 |
| Higgins | Q15868032 | ||
| Higgins | Q15868032 | ||
| P101 | field of work | biostatistics | Q214746 |
| P735 | given name | Julian | Q17856012 |
| Julian | Q17856012 | ||
| P106 | occupation | professor | Q121594 |
| statistician | Q2732142 | ||
| researcher | Q1650915 | ||
| P5008 | on focus list of Wikimedia project | UniversityofYorkThesisProject | Q114588393 |
| P551 | residence | Bristol | Q23154 |
| P21 | sex or gender | male | Q6581097 |
| Q40850000 | A basic introduction to fixed-effect and random-effects models for meta-analysis |
| Q37373846 | A case study of multiple-treatments meta-analysis demonstrates that covariates should be considered |
| Q34013434 | A checklist designed to aid consistency and reproducibility of GRADE assessments: development and pilot validation |
| Q42243147 | A design-by-treatment interaction model for network meta-analysis with random inconsistency effects |
| Q45297570 | A general framework for the use of logistic regression models in meta-analysis |
| Q36193157 | A network of investigator networks in human genome epidemiology |
| Q41866179 | A re-evaluation of random-effects meta-analysis. |
| Q42680046 | A road map for efficient and reliable human genome epidemiology |
| Q34156523 | A systematic review of the use of opioids in the management of dyspnoea. |
| Q35656920 | A tool to assess the quality of a meta-analysis. |
| Q39711209 | Accounting for heterogeneity in meta-analysis using a multiplicative model-an empirical study |
| Q39088940 | Additional considerations are required when preparing a protocol for a systematic review with multiple interventions |
| Q92133290 | Adjusting trial results for biases in meta-analysis: combining data-based evidence on bias with detailed trial assessment |
| Q24187439 | Adjuvant chemotherapy for resected early-stage non-small cell lung cancer |
| Q64985521 | Allowing for informative missingness in aggregate data meta-analysis with continuous or binary outcomes: Extensions to metamiss. |
| Q30869343 | Allowing for uncertainty due to missing continuous outcome data in pairwise and network meta-analysis. |
| Q31121944 | Allowing for uncertainty due to missing data in meta-analysis--part 1: two-stage methods. |
| Q31121947 | Allowing for uncertainty due to missing data in meta-analysis--part 2: hierarchical models. |
| Q57745153 | Altering the availability or proximity of food, alcohol and tobacco products to change their selection and consumption |
| Q92886273 | Altering the availability or proximity of food, alcohol, and tobacco products to change their selection and consumption |
| Q38520172 | An empirical comparison of heterogeneity variance estimators in 12 894 meta-analyses. |
| Q38520298 | An introduction to methodological issues when including non-randomised studies in systematic reviews on the effects of interventions |
| Q52599986 | Antidepressants might work for people with major depression: where do we go from here? |
| Q38246301 | Applicability and feasibility of systematic review for performing evidence-based risk assessment in food and feed safety |
| Q37444640 | Array CGH in patients with learning disability (mental retardation) and congenital anomalies: updated systematic review and meta-analysis of 19 studies and 13,926 subjects |
| Q36737126 | Array-based comparative genomic hybridization for investigating chromosomal abnormalities in patients with learning disability: systematic review meta-analysis of diagnostic and false-positive yields |
| Q38520563 | Assessing baseline imbalance in randomised trials: implications for the Cochrane risk of bias tool. |
| Q35165728 | Assessing the impact of drinking water and sanitation on diarrhoeal disease in low- and middle-income settings: systematic review and meta-regression |
| Q36952959 | Assessment of cumulative evidence on genetic associations: interim guidelines |
| Q56880239 | Assessment of systematic effects of methodological characteristics on candidate genetic associations |
| Q47617111 | Association Between Risk-of-Bias Assessments and Results of Randomized Trials in Cochrane Reviews: the ROBES Meta-Epidemiologic Study |
| Q101211400 | Association between opioid agonist therapy use and HIV testing uptake among people who have recently injected drugs: a systematic review and meta-analysis |
| Q30244615 | Association of BCG, DTP, and measles containing vaccines with childhood mortality: systematic review |
| Q48020162 | Basics of meta-analysis: I2 is not an absolute measure of heterogeneity |
| Q51942147 | Bayesian meta-analysis and meta-regression for gene-disease associations and deviations from Hardy-Weinberg equilibrium |
| Q51263625 | Bayesian multivariate meta-analysis with multiple outcomes |
| Q51933940 | Bayesian synthesis of epidemiological evidence with different combinations of exposure groups: application to a gene-gene-environment interaction |
| Q49154218 | Being sceptical about meta-analyses: a Bayesian perspective on magnesium trials in myocardial infarction |
| Q47348492 | Between-trial heterogeneity in meta-analyses may be partially explained by reported design characteristics |
| Q40538722 | Biases in Randomized Trials: A Conversation Between Trialists and Epidemiologists. |
| Q91533481 | CINeMA: An approach for assessing confidence in the results of a network meta-analysis |
| Q34394876 | CYP2C9 gene variants, drug dose, and bleeding risk in warfarin-treated patients: a HuGEnet systematic review and meta-analysis |
| Q42657492 | Challenges in the use of literature-based meta-analysis to examine gene-environment interactions |
| Q35266148 | Characteristics of a loop of evidence that affect detection and estimation of inconsistency: a simulation study. |
| Q43038395 | Characteristics of meta-analyses and their component studies in the Cochrane Database of Systematic Reviews: a cross-sectional, descriptive analysis |
| Q38520318 | Checklists of methodological issues for review authors to consider when including non-randomized studies in systematic reviews |
| Q47104236 | Choice of implant combinations in total hip replacement: systematic review and network meta-analysis. |
| Q24197954 | Cognitive-behavioural interventions for children who have been sexually abused |
| Q24243856 | Cognitive-behavioural interventions for children who have been sexually abused |
| Q45671624 | Commentary: Heterogeneity in meta-analysis should be expected and appropriately quantified |
| Q84293798 | Comments on 'Empirical vs natural weighting in random effects meta-analysis' |
| Q29619093 | Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis |
| Q52687120 | Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis |
| Q33626084 | Comparative efficacy and safety of treatments for localised prostate cancer: an application of network meta-analysis |
| Q38802903 | Comparative performance of heterogeneity variance estimators in meta-analysis: a review of simulation studies |
| Q35612972 | Consistency and inconsistency in network meta-analysis: model estimation using multivariate meta-regression |
| Q30240586 | Control of carbapenemase-producing Enterobacteriaceae outbreaks in acute settings: an evidence review |
| Q35782230 | Controlling the risk of spurious findings from meta-regression. |
| Q24202064 | Convincing Evidence from Controlled and Uncontrolled Studies on the Lipid-Lowering Effect of a Statin |
| Q57551325 | Coronary heart disease |
| Q61853113 | Correction: Interpretation of Random Effects Meta-analysis in Decision Models |
| Q37727023 | Corticosteroids in septic shock: a systematic review and network meta-analysis. |
| Q112609330 | Data extraction methods for systematic review (semi)automation: A living systematic review |
| Q89416205 | Dealing with effect size multiplicity in systematic reviews and meta-analyses |
| Q90167033 | Design characteristics, risk of bias, and reporting of randomised controlled trials supporting approvals of cancer drugs by European Medicines Agency, 2014-16: cross sectional analysis |
| Q47251840 | Developing the WCRF International/University of Bristol Methodology for Identifying and Carrying Out Systematic Reviews of Mechanisms of Exposure-Cancer Associations |
| Q46407738 | Development of a method for adjusting trial results for biases in meta-analysis |
| Q24247967 | Dietary advice given by a dietitian versus other health professional or self-help resources to reduce blood cholesterol |
| Q28361678 | Dietary fat intake and prevention of cardiovascular disease: systematic review |
| Q92894223 | Directly Acting Oral Anticoagulants for the Prevention of Stroke in Atrial Fibrillation in England and Wales: Cost-Effectiveness Model and Value of Information Analysis |
| Q37579463 | Disagreements in meta-analyses using outcomes measured on continuous or rating scales: observer agreement study |
| Q30235013 | Does milk intake promote prostate cancer initiation or progression via effects on insulin-like growth factors (IGFs)? A systematic review and meta-analysis |
| Q63352589 | Does testosterone mediate the relationship between vitamin D and prostate cancer? A systematic review and meta-analysis protocol |
| Q36072546 | Empirical Evidence of Study Design Biases in Randomized Trials: Systematic Review of Meta-Epidemiological Studies |
| Q38672529 | Empirical evidence about inconsistency among studies in a pair-wise meta-analysis |
| Q36745021 | Estimating within-study covariances in multivariate meta-analysis with multiple outcomes. |
| Q30586122 | Evaluating the impact of imputations for missing participant outcome data in a network meta-analysis |
| Q35200686 | Evaluating the quality of evidence from a network meta-analysis. |
| Q33620679 | Evaluation of inconsistency in networks of interventions |
| Q36966424 | Evaluation of networks of randomized trials |
| Q38204523 | Evaluation of the Cochrane Collaboration's tool for assessing the risk of bias in randomized trials: focus groups, online survey, proposed recommendations and their implementation |
| Q36887082 | Evaluation of the Cochrane tool for assessing risk of bias in randomized clinical trials: overview of published comments and analysis of user practice in Cochrane and non-Cochrane reviews |
| Q26995587 | Evidence for the selective reporting of analyses and discrepancies in clinical trials: a systematic review of cohort studies of clinical trials |
| Q38237366 | Evidence-based prescribing: combining network meta-analysis with multicriteria decision analysis to choose among multiple drugs |
| Q84725756 | Expressing findings from meta-analyses of continuous outcomes in terms of risks |
| Q40481787 | Extending DerSimonian and Laird's methodology to perform network meta-analyses with random inconsistency effects. |
| Q25256652 | Five glutathione s-transferase gene variants in 23,452 cases of lung cancer and 30,397 controls: meta-analysis of 130 studies |
| Q57331652 | GISSI-Prevenzione trial |
| Q50060448 | GRADE Guidelines: 18. How ROBINS-I and other tools to assess risk of bias in non-randomized studies should be used to rate the certainty of a body of evidence. |
| Q37908778 | GRADE guidelines: 7. Rating the quality of evidence--inconsistency |
| Q24289213 | Genome-wide association studies, field synopses, and the development of the knowledge base on genetic variation and human diseases |
| Q57551327 | Genome-wide association studies, field synopses, and the development of the knowledge base on genetic variation and human diseases |
| Q39651453 | Graphical augmentations to the funnel plot assess the impact of additional evidence on a meta-analysis |
| Q38521592 | Graphical displays for meta-analysis: An overview with suggestions for practice |
| Q35009612 | Graphical tools for network meta-analysis in STATA. |
| Q46418619 | Guidance to detect, evaluate and prevent the problem of selective reporting in trial publications |
| Q53067340 | Health-related lifestyle in adults and children with primary immune thrombocytopenia (ITP). |
| Q40105294 | Heterogeneity in application, design, and analysis characteristics was found for controlled before-after and interrupted time series studies included in Cochrane reviews |
| Q24235118 | Home visiting for socially disadvantaged mothers |
| Q57950555 | How can the evaluation of genetic tests be enhanced? Lessons learned from the ACCE framework and evaluating genetic tests in the United Kingdom |
| Q28193388 | How should meta-regression analyses be undertaken and interpreted? |
| Q35180236 | Hygiene and health: systematic review of handwashing practices worldwide and update of health effects |
| Q92821320 | Impact of blinding on estimated treatment effects in randomised clinical trials: meta-epidemiological study |
| Q56669954 | Impact of drinking water, sanitation and handwashing with soap on childhood diarrhoeal disease: updated meta-analysis and meta-regression |
| Q31125687 | Implementing informative priors for heterogeneity in meta-analysis using meta-regression and pseudo data. |
| Q31159481 | Imputation methods for missing outcome data in meta-analysis of clinical trials |
| Q40380681 | Indirect evidence of reporting biases was found in a survey of medical research studies. |
| Q30969307 | Individual patient data meta-analysis of time-to-event outcomes: one-stage versus two-stage approaches for estimating the hazard ratio under a random effects model. |
| Q43810883 | Interpretation of random effects meta-analyses. |
| Q24241888 | Interventions for treating hallux valgus (abductovalgus) and bunions |
| Q24247497 | Interventions for treating hallux valgus (abductovalgus) and bunions |
| Q38520302 | Issues relating to study design and risk of bias when including non-randomized studies in systematic reviews on the effects of interventions |
| Q28239363 | Joint effects of the N-acetyltransferase 1 and 2 (NAT1 and NAT2) genes and smoking on bladder carcinogenesis: a literature-based systematic HuGE review and evidence synthesis |
| Q47094789 | Label-invariant models for the analysis of meta-epidemiological data |
| Q34177515 | Lack of evidence for the efficacy of memantine in mild Alzheimer disease. |
| Q51599066 | Linear inference for mixed treatment comparison meta-analysis: A two-stage approach |
| Q85349654 | Linear inference for mixed treatment comparison meta-analysis: a two-stage approach |
| Q23048188 | Living systematic reviews: an emerging opportunity to narrow the evidence-practice gap |
| Q28755180 | Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review |
| Q50000956 | MELODI: Mining Enriched Literature Objects to Derive Intermediates |
| Q38667172 | Machine learning to assist risk-of-bias assessments in systematic reviews. |
| Q57542420 | Making the best use of available evidence: the case of new generation antidepressants: A response to: Are all antidepressants equal? |
| Q27860655 | Measuring inconsistency in meta-analyses |
| Q73410346 | Meta-analysis |
| Q50866901 | Meta-analysis and subgroups |
| Q35853831 | Meta-analysis in occupational epidemiology: a review of practice. |
| Q30657054 | Meta-analysis of continuous outcome data from individual patients. |
| Q31116146 | Meta-analysis of genetic association studies under different inheritance models using data reported as merged genotypes |
| Q31016826 | Meta-analysis of individual patient data from randomized trials: a review of methods used in practice. |
| Q30657056 | Meta-analysis of ordinal outcomes using individual patient data. |
| Q33370319 | Meta-analysis of skewed data: combining results reported on log-transformed or raw scales |
| Q35656915 | Methodological quality of meta-analyses: matched-pairs comparison over time and between industry-sponsored and academic-sponsored reports. |
| Q37106409 | Methods to estimate the between-study variance and its uncertainty in meta-analysis |
| Q24597537 | Multiplicity of data in trial reports and the reliability of meta-analyses: empirical study |
| Q93171790 | Network meta-analysis of rare events using the Mantel-Haenszel method |
| Q50796401 | Network meta-analysis: a norm for comparative effectiveness? |
| Q34399889 | Non-invasive prenatal diagnostic test accuracy for fetal sex using cell-free DNA a review and meta-analysis |
| Q36011593 | Obstacles and opportunities in meta-analysis of genetic association studies. |
| Q33289920 | Online genetic databases informing human genome epidemiology |
| Q24202226 | Opioids for the palliation of breathlessness in advanced disease and terminal illness |
| Q47142865 | Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis |
| Q36506207 | Personal financial incentives for changing habitual health-related behaviors: A systematic review and meta-analysis |
| Q36582204 | Planning future studies based on the conditional power of a meta-analysis |
| Q77188747 | Poor systematic reviews and meta-analyses may be misleading |
| Q24197719 | Portion, package or tableware size for changing selection and consumption of food, alcohol and tobacco |
| Q24187190 | Portion, package or tableware size for changing selection and consumption of food, alcohol and tobacco. |
| Q24289190 | Predicting the extent of heterogeneity in meta-analysis, using empirical data from the Cochrane Database of Systematic Reviews |
| Q38283269 | Predictive distributions for between-study heterogeneity and simple methods for their application in Bayesian meta-analysis |
| Q30859143 | Predictive distributions were developed for the extent of heterogeneity in meta-analyses of continuous outcome data. |
| Q112569216 | Prevalence of BRAFV600 in glioma and use of BRAF Inhibitors in patients with BRAFV600 mutation-positive glioma: systematic review |
| Q112584946 | Prognostic value of test(s) for O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation for predicting overall survival in people with glioblastoma treated with temozolomide |
| Q33960469 | Protocol for a systematic review and individual participant data meta-analysis of B-type natriuretic peptide-guided therapy for heart failure. |
| Q27860672 | Quantifying heterogeneity in a meta-analysis |
| Q37335426 | ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions |
| Q36395260 | ROBIS: A new tool to assess risk of bias in systematic reviews was developed |
| Q30967870 | Random-effects meta-analysis of time-to-event data using the expectation-maximisation algorithm and shrinkage estimators. |
| Q33861327 | Randomised controlled trial of novel, simple, and well supervised weight reducing diets in outpatients. |
| Q58642689 | Rate-Constrained Ranking and the Rate-Weighted AUC |
| Q36859537 | Recent developments in meta-analysis. |
| Q36336182 | Relative and absolute risk of colorectal cancer for individuals with a family history: a meta-analysis |
| Q30770117 | Relative efficacy of differential methods of dietary advice: a systematic review |
| Q28681258 | Reporting of industry funded study outcome data: comparison of confidential and published data on the safety and effectiveness of rhBMP-2 for spinal fusion |
| Q42741401 | Reporting of systematic reviews: the challenge of genetic association studies |
| Q36817453 | Response to paper by Lang A, Edwards N, and Fleiszer A. |
| Q37080259 | Rethinking the assessment of risk of bias due to selective reporting: a cross-sectional study. |
| Q28083649 | Risk of neuropsychiatric adverse events associated with varenicline: systematic review and meta-analysis |
| Q26768419 | Risk of nosocomial respiratory syncytial virus infection and effectiveness of control measures to prevent transmission events: a systematic review |
| Q24541608 | Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review |
| Q92964533 | RoB 2: a revised tool for assessing risk of bias in randomised trials |
| Q56565523 | STrengthening the REporting of Genetic Association Studies (STREGA)-an extension of the STROBE statement |
| Q56565211 | STrengthening the REporting of Genetic Association Studies (STREGA): An Extension of the STROBE Statement |
| Q33405556 | STrengthening the REporting of Genetic Association Studies (STREGA): an extension of the STROBE statement |
| Q37314650 | STrengthening the REporting of Genetic Association studies (STREGA)--an extension of the STROBE statement |
| Q56880291 | STrengthening the REporting of Genetic Association studies (STREGA)—an extension of the STROBE statement |
| Q30486207 | Safety and effectiveness of recombinant human bone morphogenetic protein-2 for spinal fusion: a meta-analysis of individual-participant data |
| Q41471697 | Sample size calculation for meta-epidemiological studies. |
| Q47341989 | Screening strategies for atrial fibrillation: a systematic review and cost-effectiveness analysis. |
| Q91884099 | Selection bias introduced by informative censoring in studies examining effects of vaccination in infancy |
| Q24289522 | Sequential methods for random-effects meta-analysis |
| Q34497859 | Seven haemostatic gene polymorphisms in coronary disease: meta-analysis of 66,155 cases and 91,307 controls. |
| Q37299016 | Seven lipoprotein lipase gene polymorphisms, lipid fractions, and coronary disease: a HuGE association review and meta-analysis |
| Q34081552 | Simultaneous comparison of multiple treatments: combining direct and indirect evidence. |
| Q34513646 | Statistical heterogeneity in systematic reviews of clinical trials: a critical appraisal of guidelines and practice. |
| Q56565671 | Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE Statement |
| Q56565716 | Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE statement |
| Q44237982 | Strengthening the reporting of genetic association studies (STREGA): an extension of the strengthening the reporting of observational studies in epidemiology (STROBE) statement |
| Q37152283 | Summarising and validating test accuracy results across multiple studies for use in clinical practice |
| Q38129496 | Synthesizing evidence on complex interventions: how meta-analytical, qualitative, and mixed-method approaches can contribute |
| Q35128466 | Systematic review of controlled trials on the effectiveness of fluoride gels for the prevention of dental caries in children |
| Q24675191 | Systematic review of prevalence studies of autism spectrum disorders |
| Q30248439 | Systematic review with meta-analysis: the gastrointestinal benefits of COX-2 selective inhibitors with concomitant use of low-dose aspirin. |
| Q33414801 | Systematic reviews of genetic association studies. Human Genome Epidemiology Network |
| Q92083608 | Ten questions to consider when interpreting results of a meta-epidemiological study-the MetaBLIND study as a case |
| Q27860509 | The Cochrane Collaboration's tool for assessing risk of bias in randomised trials |
| Q56828411 | The Emergence of Networks in Human Genome Epidemiology |
| Q33691735 | The INVEST project: investigating the use of evidence synthesis in the design and analysis of clinical trials |
| Q26777980 | The Prevalence of Non-Alcoholic Fatty Liver Disease in Children and Adolescents: A Systematic Review and Meta-Analysis |
| Q35881669 | The Use of Bayesian Networks to Assess the Quality of Evidence from Research Synthesis: 2. Inter-Rater Reliability and Comparison with Standard GRADE Assessment |
| Q38814841 | The albatross plot: A novel graphical tool for presenting results of diversely reported studies in a systematic review |
| Q34161758 | The association between proximity to animal-feeding operations and community health: a protocol for updating a systematic review |
| Q33712667 | The association between the peroxisome proliferator-activated receptor-gamma2 (PPARG2) Pro12Ala gene variant and type 2 diabetes mellitus: a HuGE review and meta-analysis. |
| Q28071476 | The choice between hip prosthetic bearing surfaces in total hip replacement: a protocol for a systematic review and network meta-analysis |
| Q56828398 | The emergence of networks in human genome epidemiology: challenges and opportunities |
| Q36721160 | The impact of study size on meta-analyses: examination of underpowered studies in Cochrane reviews |
| Q38103724 | The impact of trial characteristics on premature discontinuation of antipsychotics in schizophrenia |
| Q40373458 | The interpretation of random-effects meta-analysis in decision models. |
| Q86965712 | The liver in heart failure: a biopsy and explant series of the histopathologic and laboratory findings with a particular focus on pre-cardiac transplant evaluation |
| Q89858076 | The median and the mode as robust meta-analysis estimators in the presence of small-study effects and outliers |
| Q36860713 | The range of peripapillary retinal nerve fibre layer and optic disc parameters in children aged up to but not including 18 years of age, as measured by optical coherence tomography: protocol for a systematic review |
| Q37221135 | The range of peripapillary retinal nerve fibre layer and optic disc parameters, in children aged up to but not including 18 years of age who were born prematurely: protocol for a systematic review. |
| Q24288670 | The use of Bayesian networks to assess the quality of evidence from research synthesis: 1. |
| Q37747520 | Therapeutic interventions for alcohol dependence in non-inpatient settings: a systematic review and network meta-analysis (protocol). |
| Q29615697 | Tools for assessing quality and susceptibility to bias in observational studies in epidemiology: a systematic review and annotated bibliography |
| Q52655531 | Tools for assessing risk of reporting biases in studies and syntheses of studies: a systematic review |
| Q36017145 | Treating individuals 4: can meta-analysis help target interventions at individuals most likely to benefit? |
| Q57542900 | Turning the Pump Handle: Evolving Methods for Integrating the Evidence on Gene-Disease Association |
| Q34349070 | Two-stage meta-analysis of survival data from individual participants using percentile ratios. |
| Q33576756 | Updated systematic review: associations between proximity to animal feeding operations and health of individuals in nearby communities |
| Q125423626 | Dean Langan | doctoral advisor | P184 |
| Julian Higgins | wikipedia |
Search more.